Warfarin and heparin-induced skin necrosis and the purple toe syndrome: infrequent complications of anticoagulant treatment.
Sallah
S
S
Center for Thrombosis and Hemostasis and the Division of Hematology/Oncology, University of North Carolina at Chapel Hill, 27599-7035, USA.
Thomas
D P
DP
Roberts
H R
HR
D000284:Administration, Oral; D000818:Animals; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D009336:Necrosis; D012867:Skin / Q000473:pathology*; D012871:Skin Diseases / Q000139:chemically induced*; D013577:Syndrome; D014859:Warfarin / Q000009:adverse effects* / Q000627:therapeutic use
D000925:Anticoagulants; D014859:Warfarin; D006493:Heparin